FR-188582 is a highly selective cyclooxygenase-2 (COX-2) inhibitor used for its potent anti-inflammatory effects; it demonstrates therapeutic efficacy in adjuvant-induced arthritis in rats, with ED50 values of 0.074 mg/kg and 0.063 mg/kg for adjuvant-injected and non-injected paws, respectively; its anti-inflammatory potency is approximately threefold greater than that of indomethacin.